ผู้เขียน หัวข้อ: Patients with HFrEF (irrespective of diabetes status) were randomized to dapagli  (อ่าน 10 ครั้ง)

habits

  • Jr. Member
  • **
  • กระทู้: 128
Patients with HFrEF (irrespective of diabetes status) were randomized to dapagli
« เมื่อ: พฤษภาคม 09, 2021, 22:37:43 »
Patients with HFrEF (irrespective of diabetes status) were randomized to dapagliflozin 10 mg daily (n = 2,373) versus placebo (n = 2,371). Sa Gaming
Total number of enrollees: 4,744
Duration of follow-up: 18.2 months
Mean patient age: 66 years
Percentage female: 24%
Percentage with diabetes: 42%